Cmklr1 Specific Neutra™ Antibody Products

Are you struggling with prolonged drug development timelines or inconsistent validation of metabolic disease targets? Creative Biolabs' Cmklr1 specific Neutra™ antibody products leverage advanced monoclonal antibody engineering and high-throughput epitope mapping to streamline target validation, enabling rapid therapeutic candidate screening and functional analysis.

Introduction to Cmklr1

Chemokine-like receptor 1 (Cmklr1), also known as Chemerin chemotactic receptor 1, is a G protein-coupled receptor (GPCR) predominantly expressed in immune cells, adipocytes, and endothelial tissues. It binds to the adipokine chemerin, playing critical roles in metabolic regulation, immune cell migration, and inflammatory response modulation. Cmklr1's conserved structure across mammalian species underscores its functional importance in homeostasis and disease pathophysiology.

• Structure

Cmklr1 features a seven-transmembrane domain characteristic of GPCRs, with extracellular loops mediating chemerin interaction and intracellular domains facilitating downstream signaling. Structural studies reveal a unique N-terminal cleft essential for chemerin binding and receptor activation. Post-translational modifications, including glycosylation at specific extracellular residues, enhance ligand-binding affinity and stabilize receptor conformation.

• Related Signaling Pathways

Cmklr1 activation triggers diverse pathways:

- Metabolic Regulation: Enhances insulin sensitivity via AMPK and PI3K/Akt pathways in adipocytes.

- Immune Modulation: Recruits macrophages and dendritic cells through MAPK/ERK and NF-κB cascades, amplifying pro-resolving inflammatory responses.

- Angiogenesis: Promotes endothelial cell migration via VEGF-related signaling in hypoxic microenvironments.

Fig.1 The signaling pathways activated by chemerin through its receptors Cmklr1.¹

• Associated Diseases

Cmklr1 dysregulation is implicated in obesity, type 2 diabetes, atherosclerosis, and autoimmune diseases like rheumatoid arthritis. Elevated chemerin-Cmklr1 signaling correlates with chronic adipose inflammation and insulin resistance, while impaired activity links to defective immune surveillance in cancer. Targeting Cmklr1 offers therapeutic potential for metabolic-inflammatory comorbidities.

Applications of Cmklr1 Neutralizing Antibodies

• Mechanistic Studies in Metabolic Diseases

Anti-Cmklr1 antibodies elucidate receptor-ligand dynamics in adipose inflammation and glucose homeostasis. Neutralization of chemerin signaling in diabetic models restores insulin sensitivity, supporting drug discovery for metabolic syndrome.

• Therapeutic Development for Autoimmune Disorders

By blocking Cmklr1-mediated immune cell infiltration, these antibodies reduce synovial inflammation in rheumatoid arthritis models. Their high selectivity minimizes off-target effects, positioning them as candidates for biologics development.

• Biomarker Discovery in Cardiovascular Research

Quantify soluble Cmklr1 in patient sera to correlate receptor shedding with atherosclerotic plaque progression. Antibody-based assays enable stratification of high-risk cohorts for personalized interventions.

• Preclinical Validation of Antagonists

Use neutralizing antibodies as comparators to screen small-molecule Cmklr1 inhibitors. Validate candidate efficacy in reducing macrophage-driven inflammation in obesity-associated comorbidities.

• Diagnostic Tool Development

Develop ELISA kits to measure chemerin-Cmklr1 complex levels, aiding early detection of metabolic dysregulation in clinical samples.

Our Anti-Cmklr1 Neutralizing Antibodies

Creative Biolabs' anti-Cmklr1 antibodies are rigorously validated for specificity, affinity (sub-nM KD), and functional neutralization:

• Epitope Coverage: Target extracellular domains to block chemerin binding, validated via SPR and competitive ELISA.
• Cross-Reactivity: Human and murine-specific clones enable translational studies in preclinical models.
• Functional Validation: Inhibit Cmklr1-mediated chemotaxis in macrophage migration assays and reverse insulin resistance in adipocyte cultures.
• Applications: Ideal for flow cytometry, immunohistochemistry, and in vivo neutralization studies.

Creative Biolabs' Cmklr1 specific Neutra™ antibody products empower researchers to tackle metabolic and inflammatory diseases with unmatched precision. Engineered for high reproducibility across diverse applications, these tools accelerate therapeutic discovery from target validation to preclinical testing. Contact our team today to explore custom solutions for your Cmklr1-focused projects.

REFERENCE

1. Mylonakis, Adam, et al. "The Role of Chemerin in Upper Gastrointestinal Cancer." Metabolites 14.11 (2024): 599. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/metabo14110599